Syndax Pharmaceuticals (SNDX) Reports Q2 Loss of $0.47/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: SNDX) | Delayed: 13.38 +0.23 (1.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.15 | 52 Week High | $18.03 | |||
| Open | $13.06 | 52 Week Low | $8.97 | |||
| Day High | $13.56 | P/E | N/A | |||
| Day Low | $13.05 | EPS | $0.00 | |||
| Volume | 1,091,297 | |||||
